News
US plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and Medicaid Services.
Some of the most recognizable brand names that could be impacted include Ozempic and Wegovy, two injectable drugs that ...
When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...
Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
Cosmetic surgeons are reporting a growing number of patients with sagging skin and facial hollowing after losing weight with ...
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...
Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a ...
Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...
Best Life on MSN1d
Ozempic Patients Report Another Troubling Side Effect: “I’ve Lost at Least Half My Hair”Doctors explain that hair loss related to drugs like Ozempic is usually a result of rapid weight loss, not the medications ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback